Medtronic Plc (MDT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
Nov 15, 2022: Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.
Nov 02, 2022: Medtronic launches new platform to accelerate innovation in stroke care
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Medtronic Plc (Medtronic), formerly Medtronic Inc, is a medical technology company that designs, develops, manufactures and markets a wide range of medical devices and solutions. It offers products for the treatment of heart valve disorders, heart failure, diseases of the coronary artery, aortic, peripheral vascular, venous renal and neurological diseases, spine and musculoskeletal disorders and diseases of the ear, nose, and throat. It also provides biologic solutions for the orthopedic and dental markets. In the US, the company sells its products through direct sales force, and in other countries, through direct sales representatives and independent distributors. It offers its products to hospitals, third-party healthcare providers, clinics, institutions including governmental health care programs, distributors, and group purchasing organizations in Asia Pacific, Europe, the Americas, the Middle East and Africa. Medtronic is headquartered in Dublin, Ireland.Medtronic Plc Key Recent Developments
Dec 14, 2022: Medtronic named as a leading sustainability companyNov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
Nov 15, 2022: Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.
Nov 02, 2022: Medtronic launches new platform to accelerate innovation in stroke care
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company- Medtronic Plc - Key Facts
- Medtronic Plc - Key Employees
- Medtronic Plc - Key Employee Biographies
- Medtronic Plc - Major Products and Services
- Medtronic Plc - History
- Medtronic Plc - Company Statement
- Medtronic Plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- Medtronic Plc - Business Description
- Business Segment: Cardiovascular Portfolio
- Overview
- Performance
- Business Segment: Diabetes Group
- Overview
- Performance
- Business Segment: Medical Surgical Portfolio
- Overview
- Performance
- Business Segment: Neuroscience Portfolio
- Overview
- Performance
- Geographical Segment: Emerging Markets
- Target Markets
- Performance
- Geographical Segment: Non-US Developed Markets
- Target Markets
- Performance
- Geographical Segment: The US
- Target Markets
- Performance
- R&D Overview
- Medtronic Plc - Corporate Strategy
- Medtronic Plc - SWOT Analysis
- SWOT Analysis - Overview
- Medtronic Plc - Strengths
- Medtronic Plc - Weaknesses
- Medtronic Plc - Opportunities
- Medtronic Plc - Threats
- Medtronic Plc - Key Competitors
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Medtronic Plc, Medical Equipment, Deals By Year, 2016 to YTD 2022
- Medtronic Plc, Medical Equipment, Deals By Type, 2016 to YTD 2022
- Medtronic Plc, Recent Deals Summary
- Dec 14, 2022: Medtronic named as a leading sustainability company
- Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
- Nov 15, 2022: Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.
- Nov 02, 2022: Medtronic launches new platform to accelerate innovation in stroke care
- Oct 27, 2022: Medtronic to launch new Neurovascular Co-Lab Platform
- Oct 24, 2022: dorsaVi partners with Medtronic to develop new technology
- Oct 24, 2022: Medtronic announces intention to separate its combined patient monitoring and respiratory interventions businesses
- Oct 21, 2022: Out & Equal Honors Medtronic PRIDE
- Oct 14, 2022: Medtronic to webcast renal denervation investor & analyst briefing on November 7
- Sep 30, 2022: Cloud DX announces consortium to advance affordable hospital-level care at home
- Methodology
- Ratio Definitions
- About the Publisher
- Contact the Publisher
- Disclaimer
- Medtronic Plc, Key Facts
- Medtronic Plc, Key Employees
- Medtronic Plc, Key Employee Biographies
- Medtronic Plc, Major Products and Services
- Medtronic Plc, History
- Medtronic Plc, Other Locations
- Medtronic Plc, Subsidiaries
- Medtronic Plc, Key Competitors
- Medtronic Plc, Ratios based on current share price
- Medtronic Plc, Annual Ratios
- Medtronic Plc, Interim Ratios
- Medtronic Plc, Medical Equipment, Deals By Year, 2016 to YTD 2022
- Medtronic Plc, Medical Equipment, Deals By Type, 2016 to YTD 2022
- Medtronic Plc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- Medtronic Plc, Performance Chart (2018 - 2022)
- Medtronic Plc, Ratio Charts
- Medtronic Plc, Medical Equipment, Deals By Year, 2016 to YTD 2022
- Medtronic Plc, Medical Equipment, Deals by Type, 2016 to YTD 2022
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Baxter International Inc
- Siemens Healthineers AG
- Becton Dickinson and Co
- Stryker Corp
- Abbott Laboratories
- Baxter International Inc
- Siemens Healthineers AG
- Becton Dickinson and Co
- Edwards Lifesciences Corp
- The Cooper Companies Inc
- Fonar Corp
- Boston Scientific Corp
- Zimmer Biomet Holdings Inc
- Stryker Corp
- Fonar Corp
- Edwards Lifesciences Corp
- Boston Scientific Corp
- Abbott Laboratories
- The Cooper Companies Inc
- Zimmer Biomet Holdings Inc
